Literature DB >> 8939325

Creutzfeldt-Jakob disease in Canada. Laboratory Centre for Disease Control.

.   

Abstract

Mesh：

Year:  1996        PMID： 8939325      PMCID： PMC2146934     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  9 in total

Review 1.  "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease.

Authors:  P Brown; M A Preece; R G Will
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

Review 2.  Growth hormone therapy in Canada: end of one era and beginning of another.

Authors:  H J Dean; H G Friesen
Journal:  CMAJ       Date:  1986-08-15       Impact factor: 8.262

3.  Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families.

Authors:  L G Goldfarb; P Brown; E Mitrovà; L Cervenáková; L Goldin; A D Korczyn; J Chapman; S Gálvez; L Cartier; R Rubenstein
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

Review 4.  The human spongiform encephalopathies: kuru, Creutzfeldt-Jakob disease, and the Gerstmann-Sträussler-Scheinker syndrome.

Authors:  P Brown; D C Gajdusek
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

Review 5.  Molecular biology of prion diseases.

Authors:  S B Prusiner
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

Review 6.  The dimensions of Creutzfeldt-Jakob disease.

Authors:  L Manuelidis
Journal:  Transfusion       Date:  1994-10       Impact factor: 3.157

7.  Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases.

Authors:  P Brown; F Cathala; P Castaigne; D C Gajdusek
Journal:  Ann Neurol       Date:  1986-11       Impact factor: 10.422

Review 8.  Infectious cerebral amyloidosis: clinical spectrum, risks and remedies.

Authors:  P Brown
Journal:  Dev Biol Stand       Date:  1993

Review 9.  Neuropathology of spongiform encephalopathies in humans.

Authors:  J E Bell; J W Ironside
Journal:  Br Med Bull       Date:  1993-10       Impact factor: 4.291
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.